Medtech Startup Genetesis to Map Cardiac Disorders Backed by Mark Cuban

Nontraumatic chest pain is the second largest reason for emergency room visits, spurring roughly 8 million people to go to a hospital’s ER each year, according to data from the Centers for Disease Control and Prevention cited in a study published in JAMA. In a bid to do a better job of spotting underlying cardiac disorders earlier and triaging them, Cincinnati-based medical device startup Genetesis has developed a 3D mapping tool for clinical decision support. This week, the company closed a $1.2 million seed-stage round.